The FDA has hit the brakes on a trial aimed at assessing the possibility of making Cialis, a prescription drug for erectile dysfunction, available over-the-counter (OTC). This setback means that for now, Cialis will remain a prescription-only treatment. It’s like when you plan to go for a joyride but your parents suddenly slam on the car brakes before you can even start the engine! The FDA wants to take more time to evaluate the safety and effectiveness of an OTC version of Cialis, which requires careful scrutiny. This decision is understandable since making potent drugs like Cialis available without a prescription could have serious health consequences if misused. It’s important to ensure that patients have access to safe and effective treatments without compromising their well-being. To learn more about this pivotal trial and stay updated on any future developments, check out the underlying research.
